BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 19673418)

  • 1. [Construction and immunogenicity of chimeric peptide antigen composed of M2e and NP genes of avian influenza virus].
    Xu H; Hou H; Deng B; Zheng Q; Hou J
    Wei Sheng Wu Xue Bao; 2009 Jun; 49(6):807-12. PubMed ID: 19673418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses.
    Altstein AD; Gitelman AK; Smirnov YA; Piskareva LM; Zakharova LG; Pashvykina GV; Shmarov MM; Zhirnov OP; Varich NP; Ilyinskii PO; Shneider AM
    Arch Virol; 2006 May; 151(5):921-31. PubMed ID: 16292596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A fused gene of nucleoprotein (NP) and herpes simplex virus genes (VP22) induces highly protective immunity against different subtypes of influenza virus.
    Saha S; Yoshida S; Ohba K; Matsui K; Matsuda T; Takeshita F; Umeda K; Tamura Y; Okuda K; Klinman D; Xin KQ; Okuda K
    Virology; 2006 Oct; 354(1):48-57. PubMed ID: 16945400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice.
    Luo M; Tao P; Li J; Zhou S; Guo D; Pan Z
    J Virol Methods; 2008 Dec; 154(1-2):121-7. PubMed ID: 18789973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Construction and immunogenicity of recombinant bacteriophage T7 vaccine expressing M2e peptides of avian influenza virus].
    Xu H; Wang YW; Tang YH; Zheng QS; Hou JB
    Bing Du Xue Bao; 2013 Jun; 29(4):376-81. PubMed ID: 23895000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characterization the immunogenicity of recombinant VP2 of infectious bursal disease virus containing N-terminal M2e of avian influenza virus].
    Tang Y; Gong Y; Wang Y; Lu J; Wu P; Gao F; Chen T; He J; Hou J
    Wei Sheng Wu Xue Bao; 2012 Jun; 52(6):753-9. PubMed ID: 22934356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination with different M2e epitope densities confers partial protection against H5N1 influenza A virus challenge in chickens.
    Zhang X; Liu M; Liu C; Du J; Shi W; Sun E; Li H; Li J; Zhang Y
    Intervirology; 2011; 54(5):290-9. PubMed ID: 21228535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody and T cell responses induced in chickens immunized with avian influenza virus N1 and NP DNA vaccine with chicken IL-15 and IL-18.
    Lim KL; Jazayeri SD; Yeap SK; Mohamed Alitheen NB; Bejo MH; Ideris A; Omar AR
    Res Vet Sci; 2013 Dec; 95(3):1224-34. PubMed ID: 23948357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e.
    Park KS; Seo YB; Lee JY; Im SJ; Seo SH; Song MS; Choi YK; Sung YC
    Vaccine; 2011 Jul; 29(33):5481-7. PubMed ID: 21664216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin.
    Huleatt JW; Nakaar V; Desai P; Huang Y; Hewitt D; Jacobs A; Tang J; McDonald W; Song L; Evans RK; Umlauf S; Tussey L; Powell TJ
    Vaccine; 2008 Jan; 26(2):201-14. PubMed ID: 18063235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of the PapMV nanoparticle adjuvant property through an increased of its avidity for the antigen [influenza NP].
    Savard C; Laliberté-Gagné MÈ; Babin C; Bolduc M; Guérin A; Drouin K; Forget MA; Majeau N; Lapointe R; Leclerc D
    Vaccine; 2012 Mar; 30(15):2535-42. PubMed ID: 22326774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A recombinant vesicular stomatitis virus replicon vaccine protects chickens from highly pathogenic avian influenza virus (H7N1).
    Kalhoro NH; Veits J; Rautenschlein S; Zimmer G
    Vaccine; 2009 Feb; 27(8):1174-83. PubMed ID: 19135116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hexon-modified recombinant E1-deleted adenovirus vectors as dual specificity vaccine carriers for influenza virus.
    Zhou D; Wu TL; Emmer KL; Kurupati R; Tuyishime S; Li Y; Giles-Davis W; Zhou X; Xiang Z; Liu Q; Ratcliffe SJ; Ertl HC
    Mol Ther; 2013 Mar; 21(3):696-706. PubMed ID: 23229092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation of primary influenza A virus-specific CD8+ T cell responses in aged mice through blockade of an immunoinhibitory pathway.
    DiMenna L; Latimer B; Parzych E; Haut LH; Töpfer K; Abdulla S; Yu H; Manson B; Giles-Davis W; Zhou D; Lasaro MO; Ertl HC
    J Immunol; 2010 May; 184(10):5475-84. PubMed ID: 20410485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin.
    Smith LR; Wloch MK; Ye M; Reyes LR; Boutsaboualoy S; Dunne CE; Chaplin JA; Rusalov D; Rolland AP; Fisher CL; Al-Ibrahim MS; Kabongo ML; Steigbigel R; Belshe RB; Kitt ER; Chu AH; Moss RB
    Vaccine; 2010 Mar; 28(13):2565-72. PubMed ID: 20117262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of retrovirus-expressed nucleoprotein as a vaccine against lethal influenza virus infections of chickens.
    Brown DW; Kawaoka Y; Webster RG; Robinson HL
    Avian Dis; 1992; 36(3):515-20. PubMed ID: 1329705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and application of monoclonal antibodies against avian influenza virus nucleoprotein.
    Yang M; Berhane Y; Salo T; Li M; Hole K; Clavijo A
    J Virol Methods; 2008 Feb; 147(2):265-74. PubMed ID: 18006085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice.
    Tao P; Luo M; Pan R; Ling D; Zhou S; Tien P; Pan Z
    Antiviral Res; 2009 Mar; 81(3):253-60. PubMed ID: 19135483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant influenza A virus nucleoprotein is preferentially localized in the cytoplasm and its immunization in mice shows higher immunogenicity and cross-reactivity.
    Ohba K; Yoshida S; Zahidunnabi Dewan M; Shimura H; Sakamaki N; Takeshita F; Yamamoto N; Okuda K
    Vaccine; 2007 May; 25(21):4291-300. PubMed ID: 17403560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation on construction and expression in vitro of nucleic acid vaccine of nucleoprotein of influenza virus A].
    He JF; Fang SS; Cheng XW; Zhang R; Deng P; Zhao S
    Wei Sheng Yan Jiu; 2005 Jul; 34(4):419-22. PubMed ID: 16229263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.